Dr. John Campbell

G20 and the coming pandemic

Dr. John Campbell

Show Notes

G20 Bali Leaders’ Declaration

Argentina, Australia, Brazil, Canada, China, France, Germany, Japan, India, Indonesia, Italy, Mexico, Russia, South Africa, Saudi Arabia, South Korea, Turkey, United Kingdom, United States, and European Union.

https://www.consilium.europa.eu/en/press/press-releases/2022/11/16/g20-bali-leaders-declaration/

https://www.whitehouse.gov/briefing-room/statements-releases/2022/11/16/g20-bali-leaders-declaration/

Part 22

We recognize that the extensive COVID-19 immunization is a global public good

Section 23

We recognize the need for strengthening local and regional health product manufacturing capacities

We support the WHO mRNA Vaccine Technology Transfer hub

We acknowledge the importance of shared technical standards and verification methods, to facilitate seamless international travel,

interoperability, and recognizing digital solutions and non-digital solutions,

including proof of vaccinations.

Establishment of trusted global digital health networks,

that should capitalize and build on the success of the existing standards and digital COVID-19 certificates.

Part 24

The COVID-19 pandemic has accelerated the transformation of the digital ecosystem and digital economy.

We recognize the importance of digital transformation in reaching the SDGs.

We also reaffirm the role of data for development, economic growth and social well-being.

G20 update

https://www.g20.org/wp-content/uploads/2022/11/2022-G20-Bali-Update.pdf

“Endeavour to move towards interoperability of systems including mechanisms that validate proof of vaccination,

whilst respecting the sovereignty of national health policies,

and relevant national regulations such as personal data protection and data-sharing.”

Indonesia’s Minister of Health Budi Gunadi Sadikin

https://twitter.com/TimHinchliffe/status/1592232822483419138

G20 countries should adopt digital health certificate using WHO standards

Let’s have a digital health certificate acknowledged by WHO — if you have been vaccinated or tested properly — then you can move around

(next World Health Assembly in Geneva)

WHO seem to be on it already

https://www.who.int/publications/i/item/WHO-2019-nCoV-Digital_certificates-vaccination-2021.1

Digital documentation of COVID-19 certificates: vaccination status: technical specifications and implementation guidance, 27 August 2021

Use of scan codes

Klaus Schwab, World Economic Forum (WEF) Chair

Attended

From a doctor in Austria

It is currently a very emotional situation in my hospital

(and in general in hospitals in Austria)

because many of us in the health care sector are more or less forced to get a fourth vaccine dose.

Even in my case as a physician who has received three doses and one infection just 6 months ago.

The rule is that if the last vaccination is more than one year and/or the last infection is more than 6 months ago you either have to test all 72 hours or to get an additional vaccine dose;

if not you are at risk of having to pay 500 to 3600 Euros and may even get fired.

Vaccine passports https://lc.org/newsroom/details/111722-world-leaders-agree-to-implement-vaccine-passports-1 Learn more about your ad choices. Visit megaphone.fm/adchoices

More from Dr. John Campbell

Oct 25, 2026

Covid-19: Researcher blows the whistle on data integrity issues in Pfizer’s vaccine trial, Revelations of poor practices at a contract research companyhttps://www.bmj.com/content/375/bmj.n2635Uploaded 06-11-21Pfizer’s pivotal covid-19 vaccine trial, raise questions about data integrity and regulatory oversightThis was the original paperhttps://www.nejm.org/doi/full/10.1056/nejmoa2034577 Autumn 2020Pfizer’s chairman and chief executive, Albert BourlaAs I’ve said before, we are operating at the speed of scienceVentavia Research Grouphttps://www.ventaviaresearch.comResearchers were testing Pfizer’s vaccine at several sites in TexasA regional director, Brook Jackson has told The BMJ that the companyfalsified dataunblinded patientsemployed inadequately trained vaccinatorswas slow to follow up on adverse events reported in Pfizer’s pivotal phase III trialStaff who conducted quality control checks were overwhelmed by the volume of problems they were finding. US Food and Drug Administration (FDA) were informedVentavia fired her later the same day. The BMJ has been provided with dozens of internal company documents, photos, audio recordings, and emails.She repeatedly informed her superiorspoor laboratory managementpatient safety concernsdata integrity issuesthat drug assignment confirmation printouts were being left in participants’ charts, accessible to blinded personnel (later corrected)company wasn’t able to quantify the types and number of errors they were finding when examining the trial paperwork for quality controlICON, the contract research organisationhttps://www.iconplc.com/services/clinical-research-services/data-management/?creative=528047015643&keyword=small%20clinical%20research%20organizations&matchtype=b&network=g&device=c&campaignid=6471798703&adgroupid=124362508020&feeditemid=54055202224&adposition=&gclid=CjwKCAjwz5iMBhAEEiwAMEAwGB-tlgJ18Rir0V_YfW6YdQNvt33JmuRwwwZiAkL22Zh99BWJbYLb2xoCWKUQAvD_BwEICON then highlighted over 100 outstanding queries older than three daysWorries over FDA inspectionConcerns raisedParticipants placed in a hallway after injection and not being monitored by clinical staffLack of timely follow-up of patients who experienced adverse eventsProtocol deviations not being reportedVaccines not being stored at proper temperaturesMislabelled laboratory specimensTargeting of Ventavia staff for reporting these types of problems.FDA advisory committee meeting held on 10 December 2020Problems at Ventavia not mentionedThe next day the FDA issued the authorisation of the vaccine In August this year, after full FDA approval of Pfizer’s vaccineFDA published that 9 of the trials 153 sites were inspectedFDA, full trial swabs were not taken from 477 people with suspected cases of symptomatic covid-19Other employees’ accountseverything that you complained about was spot onTwo former Ventavia employees spoke to The BMJ anonymously for fear of reprisal and loss of job prospects in the tightly knit research communityI don’t think it was good clean dataIt’s a crazy messPfizer has hired Ventavia as a research subcontractor on four other vaccine clinical trialscovid-19 vaccine in children and young adultspregnant womena booster dosean RSV vaccine trialNCT04816643, NCT04754594, NCT04955626, NCT05035212). Learn more about your ad choices. Visit megaphone.fm/adchoices Learn more about your ad choices. Visit megaphone.fm/adchoices

Oct 25, 2026

Discussion about multicultural aspect of health care.Uploaded 01-10-23The Liger, Rex Soderlundhttps://theliger.substack.com/p/understanding-ecological-technologyWefwafwa’s channelhttps://www.youtube.com/@WefwafwaAndrew Learn more about your ad choices. Visit megaphone.fm/adchoices Learn more about your ad choices. Visit megaphone.fm/adchoices

Oct 25, 2026

Cardiovascular Effects of the BNT162b2 mRNA COVID-19 Vaccine in AdolescentsUploaded 16-08-22https://www.preprints.org/manuscript/202208.0151/v1Study focuses on cardiovascular effects, particularly myocarditis and pericarditis events, after BNT162b2 mRNA COVID-19 vaccine injection,in Thai adolescents, 13 to 18, both sexes This prospective cohort study,students from two schools aged 13–18 years,who received the second dose of the BNT162b2 vaccine. All healthy and without any abnormal symptoms before receiving the second dose of vaccine. Data collectedDemographicsSymptomsVital signsECG, echocardiographyCardiac enzymesCollected at baseline, Day 3, Day 7, and Day 14N = 314Analysis, n = 301Cardiovascular effectsFound in 29.24% of patients,ranging from tachycardia, palpitation, and myopericarditis. Most common cardiovascular effectsTachycardia, 7.64%Shortness of breath, 6.64%Palpitation, 4.32%Chest pain, 4.32%Hypertension, 3.99%Abnormal ECG finding, 54 patients (17.94%) Seven participants (2.33%)(all male)At least one elevated cardiac biomarker or positive lab assessmentsMyopericarditisConfirmed in one patient after vaccination. Two patients had suspected pericarditisFour patients had suspected subclinical myocarditis Three patients had minimal pericardial effusion Myocarditis and Sudden Cardiac Death in the Younghttps://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.107.693085Myocarditis accounts for up to 20% of sudden cardiac deaths in young adults. During the follow-up period, (14 days)After receiving the second dose of vaccine, two patients were hospitalized,one patient was supervised in the ICU during hospitalization, (mainly for observation of arrhythmia).ConclusionThe clinical presentation of myopericarditis after vaccination was usually mild, with all cases fully recovering within 14 days. Hence, adolescents receiving mRNA vaccines should be monitored for side effects. Clinical Trial Registration: NCT05288231Incidence, risk factors, natural history, and hypothesised mechanisms of myocarditis and pericarditis following covid-19 vaccination: living evidence syntheses and reviewhttps://www.bmj.com/content/378/bmj-2021-069445Male adolescents and male young adults are at the highest risk of myocarditis after an mRNA vaccination.https://www.cdc.gov/coronavirus/2019-ncov/vaccines/index.htmlVaccines for COVID-19COVID-19 vaccines are safe, effective, and free.COVID-19 Vaccines for Children and Teenshttps://www.cdc.gov/coronavirus/2019-ncov/vaccines/recommendations/children-teens.htmlCDC recommends covid -19 vaccines for everyone 6 months and older and boosters for everyone 5 years and older, Learn more about your ad choices. Visit megaphone.fm/adchoices Learn more about your ad choices. Visit megaphone.fm/adchoices

Oct 25, 2026

The War on Ivermectin by Dr. Pierre Kory, https://www.amazon.com/War-Ivermectin-Medicine-Millions-Pandemic/dp/151077386X/ref=sr_1_1?dib=eyJ2IjoiMSJ9.EVlbDojnY-TDtm3BgepTIg.q5qDUxkwO3stZL9DZRUFMVYBLM5ix5BlzBT_LKusDLA&dib_tag=se&keywords=kory+the+war+on+ivermectin&qid=1762207712&sr=8-1 COVID-19 treatment: real-time analysis of 6,252 studies, https://c19early.org/ Learn more about your ad choices. Visit megaphone.fm/adchoices

Oct 25, 2026

Clip from talk with Neil Oliver, Tim Kelly and John Campbell. Times and opinions have changed.Check out Neil's channel as well, https://www.youtube.com/@Neil-OliverFollow Tim on X, https://x.com/DrTimothyKelly Uploaded 16-06-25Learn more about your ad choices. Visit megaphone.fm/adchoices Learn more about your ad choices. Visit megaphone.fm/adchoices

See all episodes →